Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA Hannah A. Blair Adis Drug Q&A 06 November 2019 Pages: 583 - 591
Fremanezumab in the prevention of migraine: a profile of its use Yvette N. Lamb Adis Drug Q&A 22 October 2019 Pages: 592 - 600
Fluticasone propionate/formoterol fumarate in children aged ≥ 5 years with asthma: a profile of its use Emma D. DeeksZaina T. Al-Salama Adis Drug Q&A 04 November 2019 Pages: 601 - 606
Patchy evidence in skin-picking disorder supports management with combined behavioural and drug treatments Adis Medical Writers Disease Management 01 October 2019 Pages: 607 - 611
Manage vulvodynia using a multimodal and individualized approach Adis Medical Writers Disease Management 15 October 2019 Pages: 612 - 617
First reports of adverse drug reactions Drug Reactions and Interactions 08 November 2019 Pages: 618 - 618
Vitamin D with calcium supplements: a new hope for the treatment of dengue infection Muhammad Torequl Islam Letter to the Editor 03 October 2019 Pages: 619 - 620
Association between variants of COQ2 and TNF-α genes and statin-induced toxicities in Bangladeshi hyperlipidemic patients Fabliha Ahmed ChowdhuryS. M. E. Al BakerAbul Hasnat Original Research Article 19 October 2019 Pages: 621 - 626
Adverse events and monitoring requirements associated with monoclonal antibody therapy in patients with multiple sclerosis Yara Dadalti Fragoso Therapy in Practice 19 October 2019 Pages: 627 - 634
Correction to: Insulin glargine/lixisenatide in type 2 diabetes: a profile of its use Emma Deeks Correction Open access 14 October 2019 Pages: 635 - 635